
Russia’s Petrovax has started a late-stage trial of a COVID-19 candidate vaccine from CanSino Biologics Inc in the country, records show, as the Chinese drug firm steps up testing abroad to close in on regulatory approval. The Ad5-nCoV vaccine already has approval for use by China’s military after early and mid-stage trials, and further late-stage مزید پڑھیں












Recent Comments